Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-07
1993-12-14
Shah, Murkund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544265, 544276, 544277, A61K 3152, C07D47316, C07D47334
Patent
active
052703150
ABSTRACT:
There is provided novel 2-substituted-4-substituted-1,3-dioxolanes which are particularly useful as antiviral agents.
REFERENCES:
patent: 4000137 (1976-12-01), Dvonch et al.
patent: 4336381 (1980-11-01), Nagata et al.
patent: 4960773 (1990-10-01), Korbonits et al.
Lin et al., "Synthesis and Antiviral Activity of Various 3'-Azido, 3'-Amino, 2',3'-Unsaturated, and 2',3'-Dideoxy Analogues of pyrimidine Deoxyribonucleosides against Retroviruses", J. Med. Chem. 30, 440-444, 1987.
Chemical and Engineering News, vol. 67(26), 1989, pp. 7-15.
Mark K. Sachs, Arch. Intern. Med. vol. 152, 1992, pp. 485-501.
Mitsuya et al., Proc. Natl. Acad. Sci USA, vol. 83, 1986, pp. 1911-1915.
Baba et al., Biochemical and Biophysical Research Communication, vol. 142(1), 1987, pp. 128-134.
P. Herdewijn and E. De Clercq, "Dideoxynucleoside Analogues As Inhibitors of HIV Replication", Design of anti-Aids Drugs, E. De Clercq, ed. (Elsevier, 1990).
Baba et al., "Both 2', 3'-Dideoxythymidine and its 2',3+-Unsaturated Derivative (2',3'-Dideoxythymidinene) are Potent and Selective Inhibitors of Human Immunodeficiency Virus Replication in vitro", Biochemical and Biophysical Research Communications, 142(1) pp. 128-134 (1987).
Balzarini et al., "Potent and Selective Anti-HTLV-III/LAV Activity of 2',3'-Dideoxycytidinene, the 2',3'-Unsaturated Derivative of 2',3'-Dideoxycytidine", Biochemical and Biophysical Research Communications, 140(2), pp. 735-742 (1986).
Belleau et al., "Design and Activity of A Novel Class of Nucleoside Analogs Effective Against HIV-1", Fifth International Conference on AIDS, Montreal, Canada, Abstract T.C.O. 1 (1989).
Carlisle et al., "Cellular Pharmacology of the Anti-HIV Agent BCH-189 (2'-Deoxy-3'-Thiacytidine) In Human Peripheral Blood Mononuclear Cells (PBMC)", American Association for Cancer Research Proceedings, 31, abstract 2435, (1990).
Gosselin et al., "Systematic Synthesis and Biological Evaluation of .alpha.-and .beta.-D-Lyxofuranosyl Nucleosides of the Five naturally Occurring Nucleic Acid Bases", J. Med. Chem., 30, pp. 982-991 (1987).
Herdewijn et al., "3'-Substituted 2',3'-Dideoxynucleoside Analogues as Potential Anti-HIV (HTLV-III/LAV) Agents", J. Med. Chem., 30, pp. 1270-1278, (1987).
Huryn et al., "Synthesis of Iso-ddA, Member Of A Novel Class of Anti-HIV Agents--Dioxolane-T, A New 2',3'-Dideoxynucleoside Prototype With In Vitro Activity Against HIV", Chemtracts-Organic Chemistry 3, pp. 249.varies.251 (1990).
Mitsuya et al., "3'-Azido-3'-Deoxythymidine (BW A509U): An Antiviral Agent that Inhibits the Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus in vitro", Proc. Natl. Acad. Sci. USA, 82, pp. 7096-7100 (1986).
Mitsuya et al., "Inhibition of the in vitro Infectivity and Cytopathic Effect of Human T-Lymphotrophic Virus Type III/Lymphadenopathy-Associated Virus (HTLV-III/LAV) by 2',3'-Dideoxynucleosides", Proc. Natl. Acad. Sci. USA, 83, pp. 1911-1915 (1986).
Norbeck et al., "(+)-Dioxolant-T", Tetrahedron Lett., 30, pp. 6263-6266 (1989).
Wainberg et al., "Anti-HIV Activity, toxicity and Pharmacokinetics of Totally Novel Nucleoside Analogs", Fifth International Conference on AIDS, Montreal, Canada, Abstract M.C.P. 63, p. 552, (1989).
Wainberg et al., "Characterization of AZT-Resistant Isolates Of HIV-1: Susceptibility To Deoxythiacytidine and Other Nucleosides", Sixth International Conference on AIDS, San Francisco, CA., vol. 3, Abstract S.B.87, p. 117, (1990).
Belleau Bernard
Dixit Dilip
Nguyen-Ba Nghe
Biochem Pharma Inc.
Gupta Y. N.
Haley, Jr. James F.
Harnett Christopher J.
McDonell Leslie A.
LandOfFree
4-(purinyl bases)-substituted-1,3-dioxlanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(purinyl bases)-substituted-1,3-dioxlanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(purinyl bases)-substituted-1,3-dioxlanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705796